2017 Q2 Form 10-Q Financial Statement

#000143774917016195 Filed on September 21, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $13.43K $3.474K
YoY Change 286.64% -5.19%
Cost Of Revenue $7.066K $1.564K
YoY Change 351.79% -2.74%
Gross Profit $6.366K $1.910K
YoY Change 233.3% -7.1%
Gross Profit Margin 47.39% 54.98%
Selling, General & Admin $60.00K $10.00K
YoY Change 500.0% 0.0%
% of Gross Profit 942.51% 523.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit 0.0%
Operating Expenses $57.23K $8.039K
YoY Change 611.84% 7.49%
Operating Profit -$50.86K -$6.129K
YoY Change 729.81% 13.02%
Interest Expense $104.00
YoY Change 50.72%
% of Operating Profit
Other Income/Expense, Net $5.041K -$104.00
YoY Change -4947.12% 50.72%
Pretax Income -$50.00K -$10.00K
YoY Change 400.0% 82.08%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$50.86K -$6.233K
YoY Change 715.96% 13.49%
Net Earnings / Revenue -378.64% -179.42%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 -$3.876K
COMMON SHARES
Basic Shares Outstanding 12.00M 10.31M shares
Diluted Shares Outstanding 12.00M

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.00 $474.00
YoY Change -99.79% -59.38%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$1.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.00 $474.00
Total Long-Term Assets -$1.00 $0.00
Total Assets $0.00 $474.00
YoY Change -100.0% -59.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $20.00K
YoY Change -100.0% 0.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $30.00K
YoY Change -100.0% 50.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $44.36K
YoY Change -3.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $44.36K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $0.00 $40.00K
YoY Change -100.0% -20.0%
SHAREHOLDERS EQUITY
Retained Earnings -$114.8K -$110.1K
YoY Change 4.24% 14.41%
Common Stock $258.00 $1.031K
YoY Change -74.98% 3.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.00 -$48.70K
YoY Change
Total Liabilities & Shareholders Equity $1.00 $474.00
YoY Change -99.79% -59.38%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$50.86K -$6.233K
YoY Change 715.96% 13.49%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$12.92K $0.00
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $129.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 129.0 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -12.92K 0.000
Cash From Investing Activities
Cash From Financing Activities 129.0 0.000
Net Change In Cash -12.79K 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$12.92K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 fngr Adjustments To Additional Paid In Capital Capital Contributed
AdjustmentsToAdditionalPaidInCapitalCapitalContributed
48559
CY2017Q2 fngr Majority Shareholder Ownership Perecentage
MajorityShareholderOwnershipPerecentage
0.873
CY2017Q2 fngr Management Fee Receivable Current
ManagementFeeReceivableCurrent
CY2017Q1 fngr Management Fee Receivable Current
ManagementFeeReceivableCurrent
1673
CY2017Q2 fngr Shares Transferred Between Shareholders
SharesTransferredBetweenShareholders
2250000
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
CY2017Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
26894
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
114551
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
65992
CY2017Q2 us-gaap Assets Current
AssetsCurrent
1
CY2017Q1 us-gaap Assets Current
AssetsCurrent
2989
CY2017Q1 us-gaap Cash
Cash
1316
CY2016Q1 us-gaap Cash
Cash
2154
CY2017Q2 us-gaap Cash
Cash
1
CY2016Q2 us-gaap Cash
Cash
474
CY2017Q2 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-1315
CY2016Q2 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-1680
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
18000000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2576750
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2576750
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2576750
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2576750
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
258
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
258
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
1564
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
5076
CY2016Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
644
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2848
CY2017Q2 us-gaap Gross Profit
GrossProfit
CY2016Q2 us-gaap Gross Profit
GrossProfit
1910
CY2017Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
539
CY2016Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2017Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-21818
CY2016Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4553
CY2017Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1673
CY2016Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
CY2017Q2 us-gaap Interest Expense
InterestExpense
35
CY2016Q2 us-gaap Interest Expense
InterestExpense
104
CY2017Q2 us-gaap Interest Paid
InterestPaid
1057
CY2016Q2 us-gaap Interest Paid
InterestPaid
104
CY2017Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
350
CY2016Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1050
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2989
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
54394
CY2017Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
21059
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
CY2017Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-22374
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1680
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
2847
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-6233
CY2017Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
CY2017Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
27500
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
2194
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
8039
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2194
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6129
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5041
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-104
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117655
CY2017Q2 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
48559
CY2016Q2 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
CY2017Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-27500
CY2016Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
CY2017Q2 us-gaap Professional Fees
ProfessionalFees
1200
CY2016Q2 us-gaap Professional Fees
ProfessionalFees
4141
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-114808
CY2017Q2 us-gaap Revenues
Revenues
CY2016Q2 us-gaap Revenues
Revenues
3474
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
-51405
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
1
CY2017Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Use of Estimates</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include accounting for potential liabilities. Actual results could differ from those estimates.</div></div></div></div></div></div>
CY2017Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10307000
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10307000

Files In Submission

Name View Source Status
0001437749-17-016195-index-headers.html Edgar Link pending
0001437749-17-016195-index.html Edgar Link pending
0001437749-17-016195.txt Edgar Link pending
0001437749-17-016195-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fngr-20170531.xml Edgar Link completed
fngr-20170531.xsd Edgar Link pending
fngr-20170531_cal.xml Edgar Link unprocessable
fngr-20170531_def.xml Edgar Link unprocessable
fngr-20170531_lab.xml Edgar Link unprocessable
fngr-20170531_pre.xml Edgar Link unprocessable
pptg20170531_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending